Top of page

https://www.phootonics.eu/

EXUS as Partner

A Cost-Effective Photonics-based Device for Early Prediction, Monitoring and Management of Diabetic Foot Ulcers

Early prediction and management of Diabetic Foot Ulcers (DFUs) is an important health factor of Europe. Recent clinical trials have concluded that NIR sensing captures oxy(deoxy)haemoglobin (HbO2, Hb) and peripheral/ tissue oxygen saturations (StO2, SpO2), thermal Infrared-IR detects hyperthermia, among Regions of Interest (ROIs) and Mid-IR contains rich information about the proteomics, lipidomics and metabolomics (e.g., glucose).

Numbers

11/2019 - 04/2023

Project duration

4,624,784,25 €

Overall Budget

ICT-05-2019

Topic

Impact

The expected impact of the PHOOTONICS project is summarized in the points below:
• PHOOTONICS a cost-effective device compared to traditional medical imaging and practices; it allows for a regular non-invasive monitoring of DFUs without any additional cost of consumables
• PHOOTONICS is a reliable and non-invasive DFU management medical device: It measures several medical indices important for DFU management and monitoring
• PHOOTONICS brings together several bio-photonics related market to deliver a portable, ease of use, non-invasive device for regular DFU monitoring

UAB METIS BALTIC

INTERUNIVERSITAIR MICRO-ELECTRONICA CENTRUM (Belgium)

ALPES LASERS SA (Switzerland)

QUEST PHOTONIC DEVICES BV

Partners

EXUS SOFTWARE MONOPROSOPI ETAIRIA PERIORISMENIS EVTHINIS (Greece)

NATIONAL TECHNICAL UNIVERSITY OF ATHENS – NTUA (Greece)

CHARITE - UNIVERSITAETSMEDIZIN BERLIN (Germany)

ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON (Greece)

UNIVERSITATEA DE MEDICINA SI FARMACIE VICTOR BABES TIMISOARA (Romania)

TIME.LEX (Belgium)

Partners